GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allegra Medical Technologies Ltd (ASX:AMT) » Definitions » Median PS Value
中文

Allegra Medical Technologies (ASX:AMT) Median PS Value

: A$0.00 (As of Today)
View and export this data going back to 2007. Start your Free Trial

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Allegra Medical Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.004. Allegra Medical Technologies's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is A$0.00.

As of today (2024-04-23), Allegra Medical Technologies's share price is A$0.029. Allegra Medical Technologies's Median PS Value is A$0.00. Therefore, Allegra Medical Technologies's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Allegra Medical Technologies's Median PS Value or its related term are showing as below:

During the past 13 years, the highest Price to Median PS Value of Allegra Medical Technologies was 3.00. The lowest was 1.27. And the median was 1.50.

ASX:AMT's Price-to-Median-PS-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.77
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Allegra Medical Technologies Median PS Value Historical Data

The historical data trend for Allegra Medical Technologies's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allegra Medical Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.07 0.08 0.06 -

Allegra Medical Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.06 - - -

Competitive Comparison

For the Medical Devices subindustry, Allegra Medical Technologies's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allegra Medical Technologies Price-to-Median-PS-Value Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Allegra Medical Technologies's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Allegra Medical Technologies's Price-to-Median-PS-Value falls into.



Allegra Medical Technologies Median PS Value Calculation

Allegra Medical Technologies's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.004*0
=0.00

10-Year Median PS Ratio is 0.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Allegra Medical Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.004.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allegra Medical Technologies  (ASX:AMT) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Allegra Medical Technologies's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=0.029/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allegra Medical Technologies Median PS Value Related Terms

Thank you for viewing the detailed overview of Allegra Medical Technologies's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Allegra Medical Technologies (ASX:AMT) Business Description

Traded in Other Exchanges
N/A
Address
18-20 Orion Road, Level 8, Lane Cove West, Sydney, NSW, AUS, 2066
Allegra Medical Technologies Ltd is engaged in the research, product development, and manufacturing of medical devices including prosthetic implant tools. It offers adult and adolescent clavicle fixation systems and pins; shoulder implants; hand fracture plates and ulna heads, compression screws, distal radius systems, and hand fracture systems; hip stems and heads, CSF cups, and evolution and resurfacing hip products; and knee replacement systems among others. It operates in two segments Orthopaedics Division, which derives the majority of its revenue sells and distributes its portfolio of medical device products. Innovation Division which invests resources into the development and commercialization of new products to take to market.